Compound ID | 729
Class: Polymer
| Spectrum of activity: | Gram-negative |
| Details of activity: | Diarrhoea caused by Clostridium difficile |
| Institute where first reported: | Genzyme Corporation |
| Year first mentioned: | 2000 |
| Highest developmental phase: | Phase 3 |
| Development status: | Inactive |
| Reason Dropped: | In phase III trials it did not show non-inferiority to vancomycin which resulted in a 6% share drop in Genzyme Corporation |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/58817179 |
| Citation: |